文献速递心境障碍

双相障碍谱系基因组学新发现:神经生物学与发育通路

New Genomics Discoveries Across the Bipolar Disorder Spectrum Implicate Neurobiological and Developmental Pathways.
PubMed 文献 · Biol Psychiatry · 2025-05-31

双相障碍(BD)具有高度遗传性,近年常见变异信号识别取得广泛进展,最新全基因组关联研究(GWAS)的多基因评分与其他风险因素结合可能具有临床效用。罕见变异在BD中的作用尚待确定,但常见变异位点注释的基因显示罕见变异富集。BD亚型遗传结构存在差异,亚型特异性GWAS样本量未与BD病例同步增长,未来需确保多样化祖先群体和全球代表性。

要点

  • 最新GWAS多基因评分结合其他风险因素可能对BD具有临床效用。
  • 常见变异位点注释基因显示罕见变异富集,但罕见变异作用尚待确定。
  • BD亚型遗传结构不同,亚型特异性GWAS样本量增长不足。

核心结论

  • BD常见变异信号识别取得广泛进展,多基因评分与其他风险因素结合可能具有临床效用。
  • 罕见变异在BD中的作用尚待确定,但常见变异位点注释基因显示罕见变异富集。
  • BD亚型遗传结构存在差异,亚型特异性GWAS将揭示亚型特异性信号和生物学机制。

研究设计与样本

  • 本文为综述,聚焦双相障碍谱系基因组学发现,未报告系统检索范围。

主要发现

  • 最新GWAS的多基因评分与其他BD风险因素结合可能提供临床效用。
  • 常见变异位点注释的基因显示罕见变异富集,但罕见变异在BD中的作用尚待确定。
  • BD亚型在遗传结构上存在差异,亚型特异性GWAS可识别亚型特异性信号和机制。

关键数值与推荐

  • 亚型特异性GWAS样本量未与BD病例以相同速率增长,需更协同努力获取未来BD GWAS参与者的该信息。
  • 需评估文化、地理及其他可能影响患者评估的系统性差异,以确保遗传研究准确纳入多样化祖先群体和全球代表性。

临床怎么用

  • 临床可关注最新GWAS多基因评分与其他BD风险因素结合应用的潜在效用。
  • 未来BD遗传研究应注重亚型特异性样本积累和多样化祖先群体代表性。

局限性

  • 罕见变异在BD中的作用尚待确定。
  • 亚型特异性GWAS样本量增长不足,限制亚型特异性信号识别。
  • 遗传研究需确保多样化祖先群体和全球代表性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Bipolar disorder (BD) is a highly heritable mental disorder that affects millions of people worldwide. Our understanding of the genetic etiology and biological processes that underlie BD have greatly increased in recent years. Extensive progress has been made in identifying common variant signals for BD, and the polygenic score from the latest genome-wide association study (GWAS) may provide some clinical utility if combined with other risk factors for BD. The role of rare variation in BD remains to be determined, although genes annotated to common variant loci are shown to be enriched for rare variation. BD subtypes have been shown to differ in their genetic architecture, and as such, genetic studies across the subtypes of the BD spectrum will identify subtype-specific signals and reveal subtype-specific biological mechanisms. Despite this, subtype-specific GWAS sample sizes have not increased at the same rate as BD cases, and more concerted efforts are required to obtain this information for participants included in future BD GWASs. Moreover, assessment of culture, geography, and other systematic differences that may impact patient assessment will be necessary to ensure accurate inclusion of diverse ancestral groups and global representation in genetic studies of BD moving forward.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. O'Connell KS, Adolfsson R, Andlauer TFM, et al. New Genomics Discoveries Across the Bipolar Disorder Spectrum Implicate Neurobiological and Developmental Pathways. Biol Psychiatry. 2025. PMID: 40456304. doi:10.1016/j.biopsych.2025.05.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。